Navigation Links
Lilly Statement on Indiana Biosciences Research Institute
Date:5/30/2013

INDIANAPOLIS, May 30, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has issued the following statement from Senior Vice President Bart Peterson regarding today's announcement introducing the Indiana Biosciences Research Institute:

"The Indiana Biosciences Research Institute will change the bio-landscape of our region. Indiana's life sciences companies spend billions of dollars in research and development each year to advance health care innovations for improved human health. The Institute will help us nurture our partnerships across the country and develop more intellectual capital here in Indiana -- allowing us to keep more research dollars in the state, attract more federal research funds, and draw top scientific minds to feed our research pipeline and local economies.

"For years, Indiana has been a life sciences leader. We have roughly 2,000 companies, big and small, that focus on life sciences in our state. Our biopharmaceutical companies, agricultural science companies, device and diagnostic companies, and world-class universities have collectively pushed Indiana to the front of the line as a life sciences hub. Moving forward, the institute will help us tear down silos and bring our organizations together – benefitting patients who desperately need better solutions for emerging diseases and other difficult health care challenges.

"This institute is unique because Lilly and other private sector companies are partnering with state government and three major universities to support its creation – and it will make all Hoosier bioscience companies, including Lilly, even stronger.  An impressive roster of collaborators, an environment that attracts national and international talent, and an infrastructure that allows us to build a deeper library of intellectual property will separate Indiana from other states attempting to replicate our success.

"A decade ago, BioCrossroads helped Indiana become a more attractive place for life sciences companies to do business. Today, we collectively take the next step with the Indiana Biosciences Research Institute."

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information ─ for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com and https://twitter.com/LillyPad_Media. C-LLY

Refer to: (317)432-5195 (m); (317)277-4021 (o) - Greg Kueterman

(Logo:  http://photos.prnewswire.com/prnh/20031219/LLYLOGO)


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
2. Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
3. Lilly Declares Second-Quarter 2013 Dividend
4. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
5. The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
6. Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration
7. Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
8. Lilly Again Named One of DiversityIncs Top 50 Companies for Diversity
9. Lilly Reports First-Quarter 2013 Results
10. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
11. Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... today announced data from the first cohort of ... trial (the OVATION Study) combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  In the first three patients ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 people suffer from ... the United States and account for one death every four minutes. Many people ... disabled. HCR ManorCare is launching a video series called “Your Brain,” in conjunction with ...
(Date:5/3/2016)... Indianapolis, IN (PRWEB) , ... May 03, 2016 ... ... employee benefits advisory organization, announces Benefits Alliance Insurance Services as the latest addition ... powerhouse Southern California-based Firm comprised of Partners Wayne Blasman, David Styles, and Paul ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... technology (IT) solutions and digital consulting services to the federal government, has been ... Indefinite Delivery / Indefinite Quantity (ID/IQ) contract in support of the U.S. Army ...
(Date:5/3/2016)... Jersey City, NJ (PRWEB) , ... May 03, ... ... today announced the general availability of the latest release of DocAve 6 ... this release, AvePoint helps organizations migrate to SharePoint 2016 and take advantage of ...
(Date:5/3/2016)... ... May 03, 2016 , ... Finding the right way to address a patient’s condition before ... is now getting on board. , “You do the right thing, at the right time, ... goes down, not up,” said Leonard M. Fromer, MD, FAAFP, from Group Practice Forum. “Even ...
Breaking Medicine News(10 mins):